As technologies emerge that enable a wide range of naturally occurring medicinal compounds to be reproduced by a host plant within a controlled environment, is it time to review the use of plants as biofactories? Innovation facilitators Agri-TechE are partnering with the life-sciences network OneNucleus to explore the market potential of using plant factories to mass produce rare drugs. Find out more about the event here.
News
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
Stevenage, UK, 26 March 2024 - Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced therapies to tackle major diseases, today announces the appointment of Ali Elsley as Finance Director.
• Leading precision medicine and nucleic acid therapy (NAT) innovators will harness their platforms to develop NAT drug candidates for novel gene targets with strong genetic association to sporadic ALS
• The programme will be supported by mechanism-based patient stratification biomarkers to identify likely responders and accelerate and derisk clinical development
Norwich Research Park showcased its latest collaborations with industry at its Enterprise Tuesday event held on Tuesday 5 March at the John Innes Conference Centre.
Cancer Research Horizons, the innovation arm of Cancer Research UK, has announced the winners of its second Innovation & Entrepreneurship Awards.
Produced using a patented dry-spinning technology - CollaFibR™ from AMSBIO is a highly consistent collagen fibre matrix that closely mimics the biomechanical and biochemical properties of natural collagen scaffolds, offering a highly accurate representation of in-vivo conditions.
These innovative collagen fibres are seamlessly produced on a commercial scale using an automated state-of-the-art Good Manufacturing Process, catering to a variety of applications in 3D cell culture and tissue engineering.
FemTech and Women’s Health start-ups urged to join Discovery Park’s growth programme, offering a support package worth over £50K
The Special Edition of the ‘Discovery Spark’ growth programme was announced at Kent & Medway Women’s Health Innovation Summit
Over 80 guests from across the biotech industry came to Stevenage Bioscience Catalyst to enjoy talks and networking with female leaders in celebration of International Women’s Day 2024 with the theme of ‘Inspire Inclusion.’
LEADING science companies and innovation parks will once again open their doors to showcase their contribution to sci-tech innovation when Cambridge Wide Open Day returns for 2024.
The event – organised annually by Hauxton-based life sciences and technology firm, o2h Group - offers a unique opportunity for ecosystem employers/ employees, sci-tech enthusiasts, and residents alike to explore Cambridge’s world-class science and technology facilities, and to meet the people behind the innovations, all in one day.
ARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITY